Abstract
The INNO-LiPA Rif.TB assay for the identification of Mycobacterium tuberculosis complex strains and the detection of rifampin (RIF) resistance has been evaluated with 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis (MDR-TB). The sensitivity when compared to conventional identification/culture methods was 82.2%, and the specificity was 66.7%; the sensitivity and specificity were 100.0% and 96.9%, respectively, for the detection of RIF resistance. This assay has the potential to provide rapid information that is essential for the effective management of MDR-TB.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibiotics, Antitubercular / pharmacology*
-
DNA-Directed RNA Polymerases
-
Drug Resistance, Bacterial*
-
Humans
-
Incidence
-
Microbial Sensitivity Tests
-
Mycobacterium tuberculosis / classification*
-
Mycobacterium tuberculosis / genetics
-
Mycobacterium tuberculosis / isolation & purification
-
Nucleic Acid Hybridization / methods*
-
Rifampin / pharmacology*
-
Sputum / microbiology*
-
Time Factors
-
Tuberculosis, Multidrug-Resistant / epidemiology
-
Tuberculosis, Multidrug-Resistant / microbiology
-
Tuberculosis, Pulmonary / epidemiology
-
Tuberculosis, Pulmonary / microbiology
Substances
-
Antibiotics, Antitubercular
-
DNA-Directed RNA Polymerases
-
RNA polymerase beta subunit
-
Rifampin